Insights on Dissemination of Lung Cancer
Recruiting · NCT07476495 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥ 18 years;
- Preoperative diagnosis of resectable stage cIA-cIIIA NSCLC (adenocarcinoma or squamous cell carcinoma);
- Patients deemed fit for surgical or multimodal treatment;
- Informed consent obtained;
- Treatment, including multimodal treatment, involving surgery.
Exclusion criteria
- Histology other than adenocarcinoma or squamous cell carcinoma;
- Other neoplastic diseases concurrent with or undergoing treatment or treated with systemic therapies in the previous three years;
- Age \<18 years;
- No need for surgery.
Where it is running
1 location listed.
- IRCCS Azienda Ospedaliero-Università di Bologna - Bologna, Bologna, Italy